Related Experiment Video

Updated: Mar 26, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.9K

siRNA targeting RBP2 inhibits expression, proliferation, tumorigenicity and invasion in thyroid carcinoma cells

Ling-Ling Kong1, Dong-Mei Man2, Tian Wang3

  • 1Department of Pathology, Basic Science School, Jining Medical University, Jining, Shandong 272067, P.R. China.

Oncology Letters
|January 21, 2016
PubMed

Insights

Small interfering RNA (siRNA) targeting retinoblastoma binding protein 2 (RBP2) significantly reduced RBP2 expression in papillary thyroid carcinoma cells. This suppression inhibited cell proliferation, invasion, migration, and tumorigenicity, suggesting RBP2 as a therapeutic target.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • Papillary thyroid carcinoma (PTC) is a prevalent endocrine malignancy.
  • Retinoblastoma binding protein 2 (RBP2) is implicated in various cancers.
  • The role of RBP2 in PTC progression requires further investigation.

Purpose of the Study:

  • To investigate the effect of RBP2 knockdown on PTC K1 cell behavior.
  • To evaluate RBP2 as a potential therapeutic target in thyroid carcinoma.

Main Methods:

  • Transfection of K1 cells with RBP2-specific small interfering RNA (siRNA).
  • Assessment of RBP2 mRNA and protein levels via RT-qPCR, Western Blot, and ICC.
  • Evaluation of cell proliferation (CCK-8), colony formation (soft agar), invasion, and migration (Transwell assay).

Main Results:

  • RBP2-siRNA significantly downregulated RBP2 mRNA and protein expression in K1 cells.
  • RBP2 knockdown suppressed cell proliferation, invasion, migration, and tumorigenicity.
  • Statistical significance (P<0.01) was observed across multiple assays.

Conclusions:

  • Targeting RBP2 with siRNA effectively inhibits key oncogenic properties of papillary thyroid carcinoma cells.
  • RBP2 downregulation reduces proliferation, invasion, migration, and tumorigenic potential.
  • RBP2 represents a promising molecular target for thyroid carcinoma therapy.
Keywords:
papillary thyroid carcinomaretinoblastoma binding protein 2siRNAsoft agar colony formation assaytranswell chamber assay

More Related Videos

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

9.7K
Spontaneous Murine Model of Anaplastic Thyroid Cancer05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

2.4K

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.3K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.9K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
10.7K